What's breaking now, across thousands of outlets.
Partnership expands vaccine maker's push into cell and gene therapies; companies target commercialisation of blood cancer treatment by 2028
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.
The approval allows toripalimab with cisplatin and paclitaxel as first-line treatment for unresectable advanced, recurrent or metastatic ESCC in adults
[Premium Times] The airport authority said it was working with health agencies to support containment efforts after Nigeria confirmed its first case following months of heightened preparedness.
Eight consulting rooms and dedicated treatment areas are planned for Hospital Maritimo, as a fresh contract offer revives a delayed […]
